Difference between revisions of "Part:BBa K3142009:Design"
(→Design Notes) |
(→References) |
||
Line 14: | Line 14: | ||
===References=== | ===References=== | ||
+ | Yang, J. Protein Structure Fingerprint Technology. [J] Bioinform, Genomics, Proteomics. 2018, 3(2): 1-3 |
Latest revision as of 21:56, 20 October 2019
Artificially designed antihypertensive heptapeptide(FKGKYYP)
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
The sequence has been optimized for lactic acid bacteria. It is a small molecule bioactive peptide that is difficult to directly biosynthesize. Therefore, the fusion expression strategy is currently used.
Source
NO
References
Yang, J. Protein Structure Fingerprint Technology. [J] Bioinform, Genomics, Proteomics. 2018, 3(2): 1-3